The present invention relates to a cabergoline crystal form L, its preparation from halogenated aromatic solvents and aliphatic hydrocarbons and to pharmaceutical compositions containing the new form.

 
Web www.patentalert.com

< Compounds for Modulating TRPV3 Function

< QUANTIFICATION OF MECHANICAL AND NEURAL CONTRIBUTIONS TO SPASTICITY

> CONTACT LENS CASES FOR DELIVERY OF OPHTHALMIC AGENTS

> NOVEL QUINONOID DERIVATIVES OF CANNABINOIDS AND THEIR USE IN THE TREATMENT OF MALIGNANCIES
~ 00613